PARP-1 inhibition to treat cancer, ischemia, inflammation.
Graziani
Grazia
G
Department of Neuroscience, Pharmacology Section, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy. graziani@med.uniroma2.it
Battaini
Fiorenzo
F
Zhang
Jie
J
D000818:Animals; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D007511:Ischemia / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy*; D000071137:Poly (ADP-Ribose) Polymerase-1; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011065:Poly(ADP-ribose) Polymerases / Q000502:physiology
D004791:Enzyme Inhibitors; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; C499320:PARP1 protein, human; D000071137:Poly (ADP-Ribose) Polymerase-1; D011065:Poly(ADP-ribose) Polymerases